Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Fisiología Experimental (IFISE) (CONICET-U.N.R.), Suipacha 570, S2002LRL, Rosario, Argentina.
Facultad de Farmacia y Bioquímica, Instituto de Investigaciones Farmacológicas (ININFA), Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina.
Arch Toxicol. 2019 Aug;93(8):2279-2294. doi: 10.1007/s00204-019-02514-6. Epub 2019 Jul 12.
Taurolithocholate (TLC) is a cholestatic bile salt that induces disinsertion of the canalicular transporter Abcc2 (Mrp2, multidrug resistance-associated protein 2). This internalization is mediated by different intracellular signaling proteins such as PI3K, PKCε and MARCK but the initial receptor of TLC remains unknown. A few G protein-coupled receptors interact with bile salts in hepatocytes. Among them, sphingosine-1 phosphate receptor 2 (S1PR2) represents a potential initial receptor for TLC. The aim of this study was to evaluate the role of this receptor and its downstream effectors in the impairment of Abcc2 function induced by TLC. In vitro, S1PR2 inhibition by JTE-013 or its knockdown by small interfering RNA partially prevented the decrease in Abcc2 activity induced by TLC. Moreover, adenylyl cyclase (AC)/PKA and PI3K/Akt inhibition partially prevented TLC effect on canalicular transporter function. TLC produced PKA and Akt activation, which were blocked by JTE-013 and AC inhibitors, connecting S1PR2/AC/PKA and PI3K/Akt in a same pathway. In isolated perfused rat liver, injection of TLC triggered endocytosis of Abcc2 that was accompanied by a sustained decrease in the bile flow and the biliary excretion of the Abcc2 substrate dinitrophenyl-glutathione until the end of the perfusion period. S1PR2 or AC inhibition did not prevent the initial decay, but they accelerated the recovery of these parameters and the reinsertion of Abcc2 into the canalicular membrane. In conclusion, S1PR2 and the subsequent activation of AC, PKA, PI3K and Akt is partially responsible for the cholestatic effects of TLC through sustained internalization of Abcc2.
牛磺胆酸(TLC)是一种胆盐,可诱导胆小管转运蛋白 Abcc2(多药耐药相关蛋白 2,Mrp2)脱插入。这种内化作用是由不同的细胞内信号蛋白介导的,如 PI3K、PKCε 和 MARCK,但 TLC 的初始受体仍然未知。一些 G 蛋白偶联受体在肝细胞中与胆盐相互作用。其中,鞘氨醇-1-磷酸受体 2(S1PR2)代表 TLC 的潜在初始受体。本研究旨在评估该受体及其下游效应物在 TLC 诱导的 Abcc2 功能障碍中的作用。在体外,通过 JTE-013 抑制 S1PR2 或通过小干扰 RNA 敲低 S1PR2 可部分防止 TLC 诱导的 Abcc2 活性降低。此外,腺苷酸环化酶(AC)/PKA 和 PI3K/Akt 抑制可部分防止 TLC 对胆小管转运蛋白功能的影响。TLC 产生 PKA 和 Akt 激活,这可被 JTE-013 和 AC 抑制剂阻断,将 S1PR2/AC/PKA 和 PI3K/Akt 连接在同一通路中。在分离的大鼠灌注肝脏中,TLC 注射引发 Abcc2 的内吞作用,伴随着胆汁流量和 Abcc2 底物二硝基苯-谷胱甘肽的胆汁排泄持续减少,直到灌注期结束。S1PR2 或 AC 抑制不能防止初始衰减,但它们加速了这些参数的恢复和 Abcc2 重新插入胆小管膜。总之,S1PR2 及其随后的 AC、PKA、PI3K 和 Akt 的激活部分负责 TLC 通过持续内化 Abcc2 引起的胆汁淤积作用。